Concord Medical Services (NYSE:CCM) Research Coverage Started at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of Concord Medical Services (NYSE:CCMGet Free Report) in a research report issued to clients and investors on Sunday. The brokerage set a “sell” rating on the stock.

Concord Medical Services Stock Performance

Shares of CCM opened at $6.50 on Friday. The stock’s fifty day simple moving average is $6.67 and its 200-day simple moving average is $6.74. Concord Medical Services has a 12-month low of $3.82 and a 12-month high of $26.70. The company has a quick ratio of 0.30, a current ratio of 0.32 and a debt-to-equity ratio of 1.14.

About Concord Medical Services

(Get Free Report)

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.

Read More

Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.